1 Introduction Until recently, the worldwide increase in obesity, characterized by a body mass index (BMI) exceeding 30 kg/m 2 , was widely considered an inevitable trend with limited hope for meaningful advances in pharmacological treatment
It's so freaking good, goes on super clear so that anyone can use it, and isn't greasy (you could slip on a silk dress after it sinks in), Cardellino says
GLP-1 RA therapy significantly improved both exercise capacity and HRQoL in individuals with obesity-related HFpEF regardless of diabetes status, but had no effect on these parameters in in HFrEF patients
DOI Zhang Q, Yan L, Lu J, Zhou X
The Medicare GLP-1 Bridge prior authorization request form is available through CMS and requires prescriber attestation of clinical eligibility criteria